| 000 | 01635 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516083845.0 | ||
| 264 | 0 | _c20120824 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1096-0945 | ||
| 024 | 7 |
_a10.1016/j.yexmp.2012.03.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOliva, Joan | |
| 245 | 0 | 0 |
_aProteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. _h[electronic resource] |
| 260 |
_bExperimental and molecular pathology _cAug 2012 |
||
| 300 |
_a26-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlcohol Drinking _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApolipoproteins _xbiosynthesis |
| 650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 |
_aCholesterol _xbiosynthesis |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aFatty Acids _xbiosynthesis |
| 650 | 0 | 4 |
_aFatty Liver, Alcoholic _xdrug therapy |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProteasome Inhibitors |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aTriglycerides _xbiosynthesis |
| 700 | 1 | _aFrench, Samuel W | |
| 700 | 1 | _aLi, Jun | |
| 700 | 1 | _aBardag-Gorce, Fawzia | |
| 773 | 0 |
_tExperimental and molecular pathology _gvol. 93 _gno. 1 _gp. 26-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yexmp.2012.03.006 _zAvailable from publisher's website |
| 999 |
_c21649541 _d21649541 |
||